Discovery of novel chromone and acrylate‐based pancreatic lipase inhibitors: Molecular modelling, synthesis, and in vitro evaluation for the treatment of obesity

Documenti analoghi

• Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease
  di: Efe Doğukan Dincel, et al.
  Pubblicazione: (2024)
• Design, synthesis and neuroprotective biological evaluation of novel HDAC6 inhibitors incorporating benzothiadiazinyl systems as cap groups
  di: Bo Han, et al.
  Pubblicazione: (2024)
• Coumarin Analogues as Promising Anti‐Obesity Agents: In Silico Design, Synthesis, and In Vitro Pancreatic Lipase Inhibitory Activity
  di: Nisha Yadav, et al.
  Pubblicazione: (2025)
• Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents
  di: Srinuvasu Nakka, et al.
  Pubblicazione: (2024)
• Discovering novel derivatives of STAT3 and HDAC inhibitors with anti‐tumor activity
  di: Yu Yang, et al.
  Pubblicazione: (2024)